Texas Instruments (TXN)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
Research Workspace
Put TXN beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Semiconductors is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue grows to $5.2 billion in Q2 2026: Revenue: $6.05B.
View ThesisRevenue growth is accelerating — up about 20% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet, guidance credibility.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 2% a day.
View RiskTexas Instruments' data center expansion has to keep compounding to justify the price. Revenue grew 28% year over year in the latest quarter. The company beat its earnings estimate by 9.6%. It trades at 39 times earnings versus a 53 times peer median. The price reflects less growth than we forecast. The primary pillar is under pressure. EPS rises to $1.91 in Q2 2026. Peer multiples imply a price about 18% below where it trades. The thesis is on watch.
Trailing returns as of 2026-11-04. TXN is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 35 analysts currently covering TXN (as of Nov 2026).
Based on 15 Wall Street analysts offering 12-month price targets for TXN in the last 4 months.
Continue this research
Compare TXN with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| TXN Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Semiconductors — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put TXN next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Grow revenue across end markets
Earnings beat and strong analog and data-center demand support revenue growth across end markets.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $311.49
The last 12 months of price, then the range of analyst 12-month targets from today’s $311.49.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Grow revenue across end markets
Above-consensus guidance and AI-driven analog demand support revenue growth across end markets.

Advances: Invest in manufacturing capacity and 300mm production
Lower capex may improve cash generation, though it could temper manufacturing investment.

Advances: Grow revenue across end markets
Quarterly sales above estimates signal stronger demand and revenue performance.
Advances: Grow revenue across end markets
Earnings and revenue topping estimates support the revenue-growth objective.

Advances: Grow revenue across end markets
Higher profit and revenue provide concrete evidence of improving business performance.
Advances: Grow revenue across end markets
Estimate-beating results and lifted outlook indicate robust demand and improving growth.

Advances: Grow revenue across end markets
Results and guidance above estimates confirm stronger near-term revenue momentum.
